General MedicationsORALStandard
EMEND
APREPITANT
Standard Dose
125MG/KIT
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview EMEND is listed in Drugs@FDA under application 207865 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient APREPITANT Form and strength FOR SUSPENSION;ORAL - 125MG/KIT Sponsor MSD MERCK CO Submission history Latest submission status date: 2019-11-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview EMEND is listed in Drugs@FDA under application 207865 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient APREPITANT Form and strength FOR SUSPENSION;ORAL - 125MG/KIT Sponsor MSD MERCK CO Submission history Latest submission status date: 2019-11-14 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.